Sensex Falls for 5th Day, Down 30 Points at over Nine-Week Low

Tata Motors suffered the most among Sensex stocks by plunging 3.27 per cent ahead of company\'s board meet tomorrow to consider rights issue.

Published: 24th March 2015 05:03 PM  |   Last Updated: 24th March 2015 05:03 PM   |  A+A-


MUMBAI: The benchmark Sensex today succumbed to a flurry of selling in the last one hour to give up initial gains and extend its losses for the fifth straight session to end 30 points down at over nine-week low.

The BSE 30-share barometer resumed better and rallied further to a high of 28,455.32, up by 263 points, on sustained capital inflows amid Asian Development Bank's (ADB) painting a positive outlook of India's economic growth.

However, a brief period of heavy selling mainly in auto, banking and IT shares at the fag-end pulled it down to a low of 28,130.09, before settling at 28,161.72, showing a fall of 30.30 points or 0.11 per cent. Today's fall takes the Sensex to its lowest closing in over nine weeks since January 16.

Similarly, the 50-issue NSE Nifty moved erratically in a range of 8,627.75 and 8,535.85 before ending at 8,542.95, a net fall of 7.95 points or 0.09 per cent. In five straight day, the NSE index has shed about 180 points.

Traders said volatility was mainly due to rolling over of positions in the futures and options segment from the near month March to April series. March derivative contracts will expire on Thursday.

On Sensex, scrips like, Tata Motors, HDFC Bank, Infosys, SBI, ICICI Bank, HUL and Hero MotoCorp suffered losses.

Tata Motors suffered the most among Sensex stocks by plunging 3.27 per cent ahead of company's board meet tomorrow to consider rights issue.

However, rise in HDFC, Bharti Airtel, Sun Pharma, RIL, Dr Reddy's Lab and Wipro among others cushioned the fall to  a major extent.

Pharma stocks attracted buyers' attention after Sun Pharma and Ranbaxy got approval from the CCI for sale of seven brands to Emcure Pharma to comply with the fair trade watchdog's conditional nod for their USD 4-billion merger.

More from Business.


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp